International Drug Policy Consortium. (2025) Call for evidence - EU Drugs Strategy and EU Action Plan: contribution by the International Drug Policy Consortium. London: International Drug Policy Consortium.
Preview | Title | Contact |
---|---|---|
|
PDF (Contribution by the International Drug Policy Consortium)
256kB |
The International Drug Policy Consortium (IDPC), a global network of over 190 civil society and community organisations, welcomes the European Commission’s call for evidence on the new EU Drug Strategy. IDPC calls on the European Commission to deliver a drug strategy that reflects the EU’s core values of human rights, social justice, and public health. This includes broadening the strategy beyond supply reduction, protecting civil society, prioritising harm reduction, supporting national innovation, and continuing to lead by example on the international stage.
- Avoid an overemphasis on supply reduction
- Safeguard civil society participation
- Reinforce an evidence- and rights-based approach
- Prioritise harm reduction and the right to health
- Enable policy innovation
- Strengthen the EU’s role at the UN
MM-MO Crime and law > Legal rights > Rights of persons who use substances (users)
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
MP-MR Policy, planning, economics, work and social services > Programme planning, implementation, and evaluation > Programme planning (strategy)
VA Geographic area > International
VA Geographic area > Europe > European Union
Repository Staff Only: item control page